✦ LIBER ✦

Safety biomarkers and the clinical development of oncology therapeutics: Considerations for cardiovascular safety and risk management

✍ Scribed by Howard Fingert; Mary Varterasian

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of the patient and clinical risk

✍ M. Di Stefano; E.Rossi; S. Baccetti; F. Firenzuoli; T. bellandi; R. Tartaglia; S 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 76 KB

Ongoing Clinical Trials Evaluating the C

✍ Vivian A. Fonseca 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 213 KB

Polymeric carriers: Preclinical safety a

✍ Rogério Gaspar; Ruth Duncan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 485 KB

Clinical risk management and the ethics

✍ Megan-Jane Johnstone 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Safety pharmacology requirements for the

✍ Ian Mackenzie 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

The safety of therapeutic monoclonal ant

✍ Catapano, A.L.; Papadopoulos, N. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 972 KB